These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 32098644)
1. Interim estimates of 2019/20 vaccine effectiveness during early-season co-circulation of influenza A and B viruses, Canada, February 2020. Skowronski DM; Zou M; Sabaiduc S; Murti M; Olsha R; Dickinson JA; Gubbay JB; Croxen MA; Charest H; Jassem A; Krajden M; Bastien N; Li Y; De Serres G Euro Surveill; 2020 Feb; 25(7):. PubMed ID: 32098644 [TBL] [Abstract][Full Text] [Related]
2. Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada. Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay JB; Drews SJ; Martineau C; Charest H; Krajden M; Bastien N; Li Y J Infect Dis; 2017 Dec; 216(12):1487-1500. PubMed ID: 29029166 [TBL] [Abstract][Full Text] [Related]
3. Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Winter AL; Dickinson JA; Gubbay J; Fonseca K; Charest H; Krajden M; Petric M; Mahmud SM; Van Caeseele P; Bastien N; Eshaghi A; Li Y J Infect Dis; 2015 Sep; 212(5):726-39. PubMed ID: 25784728 [TBL] [Abstract][Full Text] [Related]
4. Estimates of influenza vaccine effectiveness for 2007-2008 from Canada's sentinel surveillance system: cross-protection against major and minor variants. Janjua NZ; Skowronski DM; De Serres G; Dickinson J; Crowcroft NS; Taylor M; Winter AL; Hottes TS; Fonseca K; Charest H; Drews SJ; Sabaiduc S; Bastien N; Li Y; Gardy JL; Petric M J Infect Dis; 2012 Jun; 205(12):1858-68. PubMed ID: 22492921 [TBL] [Abstract][Full Text] [Related]
5. Interim estimates of influenza vaccine effectiveness in 2012/13 from Canada's sentinel surveillance network, January 2013. Skowronski DM; Janjua NZ; De Serres G; Dickinson JA; Winter AL; Mahmud SM; Sabaiduc S; Gubbay JB; Charest H; Petric M; Fonseca K; Van Caeseele P; Kwindt TL; Krajden M; Eshaghi A; Li Y Euro Surveill; 2013 Jan; 18(5):. PubMed ID: 23399422 [TBL] [Abstract][Full Text] [Related]
6. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season. Skowronski DM; Janjua NZ; De Serres G; Winter AL; Dickinson JA; Gardy JL; Gubbay J; Fonseca K; Charest H; Crowcroft NS; Fradet MD; Bastien N; Li Y; Krajden M; Sabaiduc S; Petric M Clin Infect Dis; 2012 Aug; 55(3):332-42. PubMed ID: 22539661 [TBL] [Abstract][Full Text] [Related]
7. Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. Skowronski DM; De Serres G; Dickinson J; Petric M; Mak A; Fonseca K; Kwindt TL; Chan T; Bastien N; Charest H; Li Y J Infect Dis; 2009 Jan; 199(2):168-79. PubMed ID: 19086914 [TBL] [Abstract][Full Text] [Related]
8. Interim estimates of 2013/14 vaccine effectiveness against influenza A(H1N1)pdm09 from Canada s sentinel surveillance network, January 2014. Skowronski D; Chambers C; Sabaiduc S; De Serres G; Dickinson J; Winter A; Fonseca K; Gubbay J; Charest H; Petric M; Krajden M; Mahmud S; Van Caeseele P; Kwindt T; Eshaghi A; Bastien N; Li Y Euro Surveill; 2014 Feb; 19(5):. PubMed ID: 24524234 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2012/13 end of season results. Andrews N; McMenamin J; Durnall H; Ellis J; Lackenby A; Robertson C; von Wissmann B; Cottrell S; Smyth B; Moore C; Gunson R; Zambon M; Fleming D; Pebody R Euro Surveill; 2014 Jul; 19(27):5-13. PubMed ID: 25033051 [TBL] [Abstract][Full Text] [Related]
10. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Kissling E; Valenciano M; Buchholz U; Larrauri A; Cohen JM; Nunes B; Rogalska J; Pitigoi D; Paradowska-Stankiewicz I; Reuss A; Jiménez-Jorge S; Daviaud I; Guiomar R; O'Donnell J; Necula G; Głuchowska M; Moren A Euro Surveill; 2014 Feb; 19(6):. PubMed ID: 24556348 [TBL] [Abstract][Full Text] [Related]
11. Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019. Skowronski DM; Leir S; Sabaiduc S; Murti M; Dickinson JA; Olsha R; Gubbay JB; Croxen MA; Charest H; Chan T; Bastien N; Li Y; Krajden M; De Serres G Euro Surveill; 2019 Jan; 24(4):. PubMed ID: 30696523 [TBL] [Abstract][Full Text] [Related]
12. Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada's Sentinel Physician Surveillance Network, January 2015. Skowronski DM; Chambers C; Sabaiduc S; De Serres G; Dickinson JA; Winter AL; Drews SJ; Fonseca K; Charest H; Gubbay JB; Petric M; Krajden M; Kwindt TL; Martineau C; Eshaghi A; Bastien N; Li Y Euro Surveill; 2015 Jan; 20(4):. PubMed ID: 25655053 [No Abstract] [Full Text] [Related]
13. Low interim influenza vaccine effectiveness, Australia, 1 May to 24 September 2017. Sullivan SG; Chilver MB; Carville KS; Deng YM; Grant KA; Higgins G; Komadina N; Leung VK; Minney-Smith CA; Teng D; Tran T; Stocks N; Fielding JE Euro Surveill; 2017 Oct; 22(43):. PubMed ID: 29090681 [TBL] [Abstract][Full Text] [Related]
14. Vaccine effectiveness in preventing laboratory-confirmed influenza in primary care patients in a season of co-circulation of influenza A(H1N1)pdm09, B and drifted A(H3N2), I-MOVE Multicentre Case-Control Study, Europe 2014/15. Valenciano M; Kissling E; Reuss A; Rizzo C; Gherasim A; Horváth JK; Domegan L; Pitigoi D; Machado A; Paradowska-Stankiewicz IA; Bella A; Larrauri A; Ferenczi A; ; Lazar M; Pechirra P; Korczyńska MR; Pozo F; Moren A; Euro Surveill; 2016; 21(7):pii=30139. PubMed ID: 26924024 [TBL] [Abstract][Full Text] [Related]
15. Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. Skowronski DM; Janjua NZ; Sabaiduc S; De Serres G; Winter AL; Gubbay JB; Dickinson JA; Fonseca K; Charest H; Bastien N; Li Y; Kwindt TL; Mahmud SM; Van Caeseele P; Krajden M; Petric M J Infect Dis; 2014 Jul; 210(1):126-37. PubMed ID: 24446529 [TBL] [Abstract][Full Text] [Related]
16. Interim Estimates of 2019-20 Seasonal Influenza Vaccine Effectiveness - United States, February 2020. Dawood FS; Chung JR; Kim SS; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Gaglani M; Dunnigan K; Foust A; Sessions W; DaSilva J; Le S; Stark T; Kondor RJ; Barnes JR; Wentworth DE; Brammer L; Fry AM; Patel MM; Flannery B MMWR Morb Mortal Wkly Rep; 2020 Feb; 69(7):177-182. PubMed ID: 32078591 [TBL] [Abstract][Full Text] [Related]
17. Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. Puig-Barberà J; Guglieri-López B; Tortajada-Girbés M; López-Labrador FX; Carballido-Fernández M; Mollar-Maseres J; Schwarz-Chavarri G; Baselga-Moreno V; Mira-Iglesias A; Díez-Domingo J; Vaccine; 2017 Dec; 35(52):7331-7338. PubMed ID: 29128380 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. Belongia EA; Kieke BA; Donahue JG; Greenlee RT; Balish A; Foust A; Lindstrom S; Shay DK; J Infect Dis; 2009 Jan; 199(2):159-67. PubMed ID: 19086915 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of influenza vaccine in preventing medically-attended influenza virus infection in primary care, Israel, influenza seasons 2014/15 and 2015/16. Yaron-Yakoby H; Sefty H; Pando R; Dichtiar R; Katz MA; Stein Y; Mandelboim M; Mendelson E; Shohat T; Glatman-Freedman A; Euro Surveill; 2018 Feb; 23(7):. PubMed ID: 29471622 [TBL] [Abstract][Full Text] [Related]
20. Interim Estimates of 2018-19 Seasonal Influenza Vaccine Effectiveness - United States, February 2019. Doyle JD; Chung JR; Kim SS; Gaglani M; Raiyani C; Zimmerman RK; Nowalk MP; Jackson ML; Jackson LA; Monto AS; Martin ET; Belongia EA; McLean HQ; Foust A; Sessions W; Berman L; Garten RJ; Barnes JR; Wentworth DE; Fry AM; Patel MM; Flannery B MMWR Morb Mortal Wkly Rep; 2019 Feb; 68(6):135-139. PubMed ID: 30763298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]